| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2139084 | Leukemia Research | 2008 | 9 Pages |
Abstract
Recent studies have suggested that flow cytometry (FCM) helps diagnose myelodysplastic syndromes (MDS). However, appropriate FCM diagnostic parameters that are easily reproducible by different examiners remain unclarified. We found that “the Ly/Mbl CD45 ratio (mean fluorescence intensity [MFI] of CD45 on lymphocytes/MFI of CD45 on CD34+ myeloblasts),” “the percentage of CD34+ myeloblasts among all nucleated cells,” and “the percentage of CD34+ B-cell precursors among all CD34+ cells” had little interexaminer variability. These parameters can be analyzed from one test tube for three-color FCM, and their analysis in combination can diagnose a certain percentage of low-grade MDS patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Chikako Satoh, Kazuo Dan, Taishi Yamashita, Risa Jo, Hideto Tamura, Kiyoyuki Ogata,